-+ 0.00%
-+ 0.00%
-+ 0.00%

PHATHOM PHARMACEUTICALS ANNOUNCES FIRST PATIENT DOSED IN PHASE 2 STUDY OF VOQUEZNA® (VONOPRAZAN) IN EOSINOPHILIC ESOPHAGITIS (EOE)

Reuters·11/04/2025 13:00:06

Please log in to view news